Researchers find that people with dementia who received the drug suvorexant showed a drop in tau and amyloid beta. The drug is already available for sleep problems in Alzheimer’s. Learn more.
NAMENDA® / EBIXA® (generic MEMANTINE) is FDA-approved for Alzheimer’s. Learn about new research on how it may help in preventing or slowing dementia.
Research shows that lecanemab is the first drug ever to slow cognitive decline in Alzheimer’s. Learn more.
Researchers have found both smoking and cardiovascular disease impair the ability to learn and memorize. Find out more.
People with Alzheimer’s are often prescribed drugs for other conditions — including diabetes or high blood pressure — at the same doses as those without dementia. That practice might need to be reexamined.
The FDA has approved the supplemental New Drug Application (sNDA) of REXULTI® (brexpiprazole) for the treatment of agitation associated with Alzheimer’s. It’s the first such treatment to be approved in the US. Learn more.
See safety and effectiveness rankings for four Alzheimer’s drugs. Ranked on concentration, memory, alertness and mood, learn what the researchers found.
An international team of researchers finds that cognitive motor training helps fight Alzheimer’s and dementia, using a fitness game to show that cognitive motor training improves both cognitive and physical skills in people with significant dementia. Find out more.
A global team of scientists has found by tracking the health of more than 31,000 adults through six longitudinal studies that treating high blood pressure with medication reduces the risk of dementia by 12 percent. It reduces the risk of developing Alzheimer’s disease even more – by 16 percent. Find out why.
Researchers in Canada find that listening to one’s favorite music, or to music that is personally significant, leads to improvement in the integrity of the brain.
PRODUCT OF THE WEEK: Caregivers love this pill box, as do patients and professionals. Simply fill it once a month. Roomy, simple, ingenious.
Caring for someone with Alzheimer’s is demanding enough. Now, instead of traveling for hours of infusions, families can turn to Leqembi IQLIK—a once-weekly injection approved by the FDA that makes treatment simpler, safer, and closer to home.
SHORT-TERM MEMORY lapses are obvious signs of Alzheimer’s, but other tell-tale signals begin to show much earlier. Learn how to look for semantic impairments, such as simple questions about size.
Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?
An intriguing study of 120 grandmothers might surprise you. Doctors know socially engaged people have better cognition and less dementia. But can a person get too much of a good thing? What’s the right balance?
Enjoy this great duet between a musician with dementia and his son. A triumph of spirit over Alzheimer’s! Sing-a-long if you like!
No spam, only news and updates.
